Doximity IPO Leaves Room for Physician Users to Get on Board
Health tech company Doximity filed for an IPO. The offering leaves a large portion of shares for its users to invest in.
Healthcare
The latest news in the healthcare sector including biotech and telehealth.
Shorts and Redditors Battle, CLOV Stock Could Surge Higher
Clover Health stock has been rising lately after being hard hit by a short-seller’s accusations. What's the price prediction for Clover Health (CLOV) stock?
There's Still Time to Buy BriaCell Therapeutics (BCTX) Stock
BriaCell Therapeutics stock has been very volatile. What’s happening with BCTX stock and is it too late to buy it now?
Centessa Pharmaceuticals to Go Public This Week—IPO Date and Price
Biopharma holding company Centessa Pharmaceuticals is going public this week. What's the company's IPO date and price?
Why Onconova Therapeutics (ONTX) Stock Is Up Sharply
Onconova Therapeutics (ONTX) stock us up sharply on May 21. What happened to ONTX stock and why is it up sharply?
Why Peloton Is a Better Home Fitness Stock to Buy Than Beachbody
FRX, which will merger with Beachbody, and Peloton have both crashed. However, PTON looks like the better home fitness stock to buy now.
Zomedica Stock Forecast 2025: Will ZOM Rise or Fall More?
Zomedica stock is now back below $1. What's the 2025 forecast for ZOM stock? Will it rise or fall more from these levels?
Why Bionovate Technologies (BIIO) Stock Is a Risky Bet in 2021
BIIO stock has fallen sharply from its peaks. What's the forecast for BIIO? Will it fall more or is it a good penny stock to buy now?
Invitae (NVTA) Stock Forecast Looks Solid Before Its Q1 Earnings
Invitae will report its first-quarter earnings results on May 4. What’s the forecast for NVTA and is it a good buy before its earnings?
How does Occidental Petroleum compare to industry peers?
In terms of profitability, OXY has the highest profit margins amongst its peers at 24.2%. OXY also has one of the highest dividend yields at 2.85%.
CYDY Stock Might See Better Days in 2021 and Rise to $10
CytoDyn stock has fallen sharply from its peaks. Why is CYDY stock falling and can it go up in 2021 and hit the $10 price level?
Amid Rotation to Value, Roche Holdings Might Be a Good Pick
Roche stock has had fairly flat price movements in 2021 YTD. What is Roche's (RHBBY) stock forecast for 2021?
MindMed (MNMD) Stock Is a Risky Bet Due to Weak Financials
On April 27, MindMed stock fell 29 percent on its Nasdaq listing debut. What’s MNMD’s forecast and is it a good buy?
Despite Its Short-Term Concerns, Clover Health (CLOV) Seems to Be the Long-Term Winner
Clover Health’s stock has seen a huge pullback following Hindernburg Research’s allegations in February. What is Clover Health’ 2025 forecast?
Who Owns Syringe Technology Company ApiJect?
ApiJect makes injectable technology and received funding to help with COVID-19 vaccine rollout. Who owns ApiJect? Is it publicly traded?
UBS Ranked Top Plant-Based Meat Stocks For a Growing Global Market
UBS ranked the top plant-based meat stocks, including flavor companies and restaurant brands, for a growing global market.
Senseonics Stock Is Speculative, Still a Buy With Good Valuations
Senseonics stock has been very volatile this year. What’s the forecast for SENS stock in 2021 and is it a good stock to buy now?
Sell-Off in ZOM Stock Isn't Over, Still a Good Long-Term Investment
Zomedica is now down almost two-thirds from its 52-week highs of $2.91. Will ZOM stock go up and is it a good long-term investment?
Agilon Health Is Going Public: All About Its IPO Date and Price
Agilon Health is going public on the NYSE and aims to raise over $1 billion. What is the companies upcoming IPO date and price?
CytoDyn Stock Forecast: Will CYDY Recover or Fall More in 2021?
CytoDyn stock has fallen almost 42 percent YTD. What’s the forecast for CYDY stock, will it recover or fall more in 2021?
Regen BioPharma Stock Has Huge Potential and Huge Risk
Regen BioPharma stock was up more than 500 percent on April 8. Is Regen Bio-Pharma (RGBP) stock a buy after this huge rally?
Zomedica (ZOM) Stock Is Dropping, Investors Should Wait to Buy
With Zomedica (ZOM) stock falling 55 percent from its highs, should you buy the dip or still stay away from the speculative penny stock?
Why Nano-X Imaging (NNOX) Stock Might Be a Risky Bet for Investors
On April 5, Nano-X Imaging (NNOX) stock is up 58 percent after the company said that it received first FDA clearance. Is NNOX stock a good buy?
Why Savara (SVRA) Might Be a Risky Bet for Investors
On March 30, Savara (SVRA) stock gained 22 percent despite no company-specific news. What’s the forecast for SVRA stock?
Walgreens Stock Looks Like a Buy Before Its Q2 Earnings
Walgreens (WBA) is scheduled to release its earnings for the second quarter of fiscal 2021 on March 31. What’s the forecast for WBA stock?
Humanigen (HGEN) Stock Looks Like a Buy Amid More COVID-19 Waves
Why is biopharma company Humanigen (HGEN) stock rising? Should investors buy the stock now or stay on the sidelines?
Is Coaching Platform BetterUp Publicly Traded?
Coaching platform BetterUp is privately held but may go public with an IPO at some point.
Aytu BioScience and Neos Merger Looks Like a Win-Win
As Aytu BioScience and Neos Therapeutics get close to completing their merger, what is AYTU’s stock forecast? Should investors buy the stock?
Why Onconova Therapeutics (ONTX) Stock Is a Speculative Bet
Onconova Therapeutics (ONTX) is on an uptrend. What's the forecast for ONTX and is it a good stock to buy for the long term?
Why Zynerba (ZYNE) Might Be a Risky Bet for Investors
On March 15, Zynerba Pharmaceuticals stock gained 49 percent despite no company-specific news. What’s the forecast for ZYNE stock in 2021?
Meme Stock ZOM is On a Move (Again), Should You Buy Now?
Pet health diagnostic company Zomedica (ZOM) is on the rise again. What’s the forecast for ZOM stock in 2021? Is it a good stock to buy?
Ridgeback Bio Draws Investor Attention After Its COVID-19 Pill Has Promising Results
Merck and Ridgeback Biotherapeutics are developing molnupiravir, an oral antiviral for the treatment of COVID-19. Is Ridgeback stock publicly traded?
COVID-19 Vaccine Maker Johnson & Johnson Has a Long History
Who owns Johnson & Johnson? The publicly-traded corporation’s top stakeholders include its CEO and multiple EVPs. Learn more about the company.
OpGen’s Promising Results and Outlook for 2021 Impress Wall Street
On Mar. 8, OpGen stock rose 37 percent after the company published promising results for its pneumonia diagnostics technology. What's OPGN's stock forecast?
Wall Street Is Bullish on ORTX Stock, Outlook in 2021
Orchard Therapeutics (ORTX) stock is up sharply in 2021. What’s the forecast for ORTX stock in 2021? Is it a good stock to buy even now?
TherapeuticsMD Stock Is a Good Buy Despite Losses
On March 2, TherapeuticsMD (TXMD) stock gained as much as 12 percent after the company reported its fourth-quarter earnings results.
Did Moderna CEO Stéphane Bancel Take the Vaccine Himself?
Making a vaccine is one thing. Did the CEO of Moderna take the vaccine himself?
At-Home Fitness Company Tonal Isn't Publicly Traded Yet
Recently, at-home fitness company Tonal raised $110 million in new funds. The company isn't publicly traded. Does the company have any plans to go public?
Is Clover Health Stock a ‘10x Idea’ From Palihapitiya?
Clover Health (CLOV) stock has fallen sharply from its peaks. What's the forecast for CLOV stock in 2021? Has it bottomed out or could it fall more?
Therabody Is Privately Owned, Attracts Many Celebrity Investors
Tech wellness company Therabody has attracted many celebrity investors and isn't publicly traded. Does the company have plans to go public?
Beachbody Is Going Public in a Three-Way Merger, Expands Its Reach
Fitness and tech company Beachbody is going public in a three-way merger with a SPAC and Myx Fitness. When is the Beachbody SPAC IPO date?
Hindenburg’s Report Spells Trouble for IPOE and Palihapitiya's Other SPACs
Hindenburg Research has accused Clover Health of fraud, which impacts Chamath Palihapitiya's other SPACs including IPOE.
23andMe Is Going Public, IPO Expected in the Second Quarter
23andMe is going public through a merger with Sir Richard Branson's VGAC SPAC in the second quarter of 2021. When is the IPO date?
Ellume Would Be a ‘Millionaire-Maker’ Stock—If You Could Only Invest
Ellume has entered into a $232 million agreement with the U.S. government, and many investors want to know how to invest in Ellume stock.
Neuralink Is a Ground-Breaking Startup, Isn't Publicly Traded
Neuralink is Elon Musk's neuroscience startup, which is developing a brain-machine interface. Currently, the company is privately held. Does it have plans to go public?
Jaguar Health Pursues SPAC Merger, Seeks to Expand Portfolio
Jaguar Health is a company that develops plant-based pharmaceuticals. Currently, the company is pursuing a SPAC merger. What can investors expect?
Bionano Genomics Stock Has Huge Upside Despite the Recent Run-Up
Recently, Bionano stock has seen a surge. Based on the company's financials, how does BNGO's stock forecast look? Is there more upside despite the recent run-up?
ACRX Stock Has a Strong Start in 2021, Still a Risky Bet for Investors
AcelRx is a specialty pharmaceutical company focused on developing and commercializing innovative therapies. What's ACRX's stock forecast?
Oren Frank and His Wife Started Talkspace to Make a Difference
Oren Frank and his wife, Roni Frank, founded Talkspace as a solution for people in need of mental health help. So, who is Oren Frank?
Elizabeth Holmes Lost Her Billions When Theranos Went Under
Elizabeth Holmes, the shamed founder of defunct health tech startup Theranos, faces criminal fraud charges. Is she still a billionaire?